New Rhein Healthcare
New Rhein is a private equity investment firm based in Philadelphia, focusing on healthcare therapeutics and medical devices. Established in 2010, the firm is managed by partners and associates who are former industry executives with extensive operational and transactional experience. New Rhein targets investments in businesses that leverage proven products for new applications, such as new indications and dosage forms. The firm collaborates with a network of operationally focused investors to provide comprehensive support for its portfolio companies in various areas, including development, regulatory compliance, reimbursement, marketing, and contract manufacturing. Additionally, New Rhein helps these companies define their value propositions to attract strategic partners. The firm has previously invested in sectors such as ophthalmic pharmaceuticals, molecular diagnostics, and respiratory drug/device inhalers.
Neuraptive Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative therapeutics and medical products for the treatment of peripheral nerve injuries (PNI). The company offers a range of products, including AxoFuse, a nerve repair system designed to prevent nerve degeneration and limb atrophy; AxoTrim, a surgical instrument for preparing nerves for suturing; and AxoBond, which secures surgically repaired nerves during recovery. Additionally, Neuraptive is working on NTX-001, a drug-device product intended for use in surgical nerve repairs and reconstructive procedures. Founded in 2016, the company aims to address the unmet medical needs of patients and physicians dealing with acute nerve injuries. Neuraptive is headquartered in Lafayette, Colorado, with additional offices in Philadelphia, Pennsylvania, and Louisville, Colorado.
Neuraptive Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative therapeutics and medical products for the treatment of peripheral nerve injuries (PNI). The company offers a range of products, including AxoFuse, a nerve repair system designed to prevent nerve degeneration and limb atrophy; AxoTrim, a surgical instrument for preparing nerves for suturing; and AxoBond, which secures surgically repaired nerves during recovery. Additionally, Neuraptive is working on NTX-001, a drug-device product intended for use in surgical nerve repairs and reconstructive procedures. Founded in 2016, the company aims to address the unmet medical needs of patients and physicians dealing with acute nerve injuries. Neuraptive is headquartered in Lafayette, Colorado, with additional offices in Philadelphia, Pennsylvania, and Louisville, Colorado.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.